Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice
F Xu, KY Wang, N Wang, G Li, D Liu - PloS one, 2017 - journals.plos.org
Glucagon-like peptide 1 (GLP-1) is a very potent insulinotropic hormone secreted into the
blood stream after eating. Thus, it has potential to be used in therapeutic treatment of …
blood stream after eating. Thus, it has potential to be used in therapeutic treatment of …
GLP-1 analogues
R Thennati, N Chaturvedi, VS Burade… - US Patent …, 2022 - Google Patents
6,268,343 B1 6,620,910 B1 6,849,708 B1 7,084,243 B2 7,291,594 B2 7,482,321 B2
7,893,017 B2 7,897,566 B2 8,603,972 B2 8,648,041 B2 8,951,959 B2 9,006,178 B2 …
7,893,017 B2 7,897,566 B2 8,603,972 B2 8,648,041 B2 8,951,959 B2 9,006,178 B2 …
GLP-1 compositions and uses thereof
EH Moeller, MD Soerensen, J Lundqvist - US Patent 11,752,198, 2023 - Google Patents
US11752198B2 - GLP-1 compositions and uses thereof - Google Patents US11752198B2 -
GLP-1 compositions and uses thereof - Google Patents GLP-1 compositions and uses thereof …
GLP-1 compositions and uses thereof - Google Patents GLP-1 compositions and uses thereof …
GLP-1 compositions and uses thereof
DK Engelund, S Snitker, AM Louw - US Patent 11,318,191, 2022 - Google Patents
US11318191B2 - GLP-1 compositions and uses thereof - Google Patents US11318191B2 -
GLP-1 compositions and uses thereof - Google Patents GLP-1 compositions and uses thereof …
GLP-1 compositions and uses thereof - Google Patents GLP-1 compositions and uses thereof …
GLP-1 analogues
R Thennati, N Chaturvedi, VS Burade… - US Patent …, 2022 - Google Patents
6,620,910 B1 6,849,708 B1 7,084,243 B2 7,291,594 B2 7,482,321 B2 7,893,017 B2
7,897,566 B2 8,603,972 B2 8,648,041 B2 8,951,959 B2 9,006,178 B2 9,266,940 B2 …
7,897,566 B2 8,603,972 B2 8,648,041 B2 8,951,959 B2 9,006,178 B2 9,266,940 B2 …
Derivatives of GLP-1 like peptides, and uses thereof
S Reedtz-Runge, J Kofoed - US Patent 10,010,614, 2018 - Google Patents
The invention relates to derivatives of GLP-1 like peptides which are C-terminally extended
analogs of native GLP-1. The derivatives comprise two side chains, one at a position …
analogs of native GLP-1. The derivatives comprise two side chains, one at a position …
Polypeptide conjugates and methods of uses
Y Zhang, X Wu, ZOU Haixia, P Zhai… - US Patent …, 2022 - Google Patents
7,576,059 B2 7,893,017 B2 8,097,698 B2 8,129,343 B2 8,445,433 B2 8,536,122 B2
8,563,521 B2 8,603,972 B2 8,648,041 B2 8,673,860 B2 8,895,694 B2 8,957,021 B2 …
8,563,521 B2 8,603,972 B2 8,648,041 B2 8,673,860 B2 8,895,694 B2 8,957,021 B2 …
Conjugates of fusion proteins of GLP-1 and FGF21
X Wu, ZOU Haixia, Y Zhang, B Wu, W Guo - US Patent 11,510,990, 2022 - Google Patents
2021-09-26 Assigned to BEIJING QL BIOPHARMACEUTICAL CO., LTD. reassignment
BEIJING QL BIOPHARMACEUTICAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST …
BEIJING QL BIOPHARMACEUTICAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST …
Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions
US11123405B2 - Long-acting GLP-1R agonist as a therapy of neurological and
neurodegenerative conditions - Google Patents US11123405B2 - Long-acting GLP-1R …
neurodegenerative conditions - Google Patents US11123405B2 - Long-acting GLP-1R …
GLP-1 analogues
R Thennati, N Chaturvedi, VS Burade… - US Patent …, 2024 - Google Patents
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical class C ([C@@
H](C (= O) N [C@@ H]([C@@ H](C) CC) C (= O) N [C@@ H](C) C (= O) N [C@@ H](CC …
H](C (= O) N [C@@ H]([C@@ H](C) CC) C (= O) N [C@@ H](C) C (= O) N [C@@ H](CC …